genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2025
Atopic dermatitis
Featured
Scratching an Itch: A Double-Edge Sword That Sharpens Inflammation and Immune Defenses
Drug Discovery
StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results
Artificial Intelligence
Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate
A-Lists
Six Companies Worthy of Note in AI Drug Discovery
Drug Discovery
Microbiome Therapeutics: Out of Range or Just Under the Radar?
Drug Discovery
StockWatch: MacroGenics Shares Crater after Trial Deaths
Artificial Intelligence
StockWatch: Nvidia Shares Leap Again after Reporting Record Revenues
Artificial Intelligence
StockWatch: Nvidia Jumps 24% on Recursion, Amgen AI Partnerships
Artificial Intelligence
Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development
GEN Edge
Up-to-$2B Sanofi Collaboration Pays Off for Kymera
1
2
3
4
Page 1 of 4
Scroll Up